Skip to search.
 FTSE 100 Down 1.72%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
11.91 Down 0.09(0.75%) 14:46
Add to Portfolio
Prev Close:12.00
Open:12.00
Bid:12.00
Ask:12.50
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:11.50 - 12.35
52wk Range:1.77 - 13.38
Volume:4,381,993
Avg Vol (3m):8,419,420
Market Cap:302.40m
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,237.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.15
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines for the treatment of cancer, and age-related or inherited neurodegenerative disorders and ocular diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback